SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00079



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00079_DPrep1 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep2 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep3 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep4 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep5 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DQrep1 19 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep2 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep3 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep4 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep5 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep6 16 Human HLA-DQA10505-DQB10301
SYSMHC00079_DRrep1 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep2 8 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep3 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep4 16 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep5 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep6 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep7 31 Human DRB1_1201,DRB3_0202



Detailed view of sample SYSMHC00079_DRrep5



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A10.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 1
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A11.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 2
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A12.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 3
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A13.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 4
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A14.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 5
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A15.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 6
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 7
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A2.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 8
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A3.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 9
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A4.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 10
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A5.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 11
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A6.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 12
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A7.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 13
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A8.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 14
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A9.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 15